1. Home
  2. BGSI vs CNTA Comparison

BGSI vs CNTA Comparison

Compare BGSI & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BGSI

Boyd Group Services Inc.

N/A

Current Price

$178.30

Market Cap

4.3B

Sector

N/A

ML Signal

N/A

Logo Centessa Pharmaceuticals plc

CNTA

Centessa Pharmaceuticals plc

HOLD

Current Price

$23.49

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BGSI
CNTA
Founded
1990
2020
Country
Canada
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3B
3.7B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
BGSI
CNTA
Price
$178.30
$23.49
Analyst Decision
Strong Buy
Analyst Count
0
10
Target Price
N/A
$38.50
AVG Volume (30 Days)
18.4K
1.6M
Earning Date
02-25-2026
03-23-2026
Dividend Yield
0.25%
N/A
EPS Growth
N/A
N/A
EPS
0.74
N/A
Revenue
$3,101,279,000.00
$15,000,000.00
Revenue This Year
$4.03
N/A
Revenue Next Year
$26.52
N/A
P/E Ratio
$308.32
N/A
Revenue Growth
1.42
118.88
52 Week Low
$136.81
$9.60
52 Week High
$178.86
$30.58

Technical Indicators

Market Signals
Indicator
BGSI
CNTA
Relative Strength Index (RSI) 69.84 43.38
Support Level $159.92 $23.41
Resistance Level $175.19 $26.51
Average True Range (ATR) 3.80 1.42
MACD 0.99 0.03
Stochastic Oscillator 90.70 40.16

Price Performance

Historical Comparison
BGSI
CNTA

About BGSI Boyd Group Services Inc.

Boyd Group Services Inc is engaged in operating non-franchised collision repair centers in North America. The Company's primary line of business is automotive collision and glass repair and related services, with the majority of revenues relating to this group of similar services. This line of business operates in Canada and the U.S. and both regions exhibit similar long-term economic characteristics. he Company is also a retail auto glass operator in the United States, under the trade names Gerber Collision & Glass, Glass America, Auto Glass Service, Auto Glass Authority, and Autoglassonly.com. In addition, the Company operates a third-party administrator, Gerber National Claims Services (GNCS), that offers glass, emergency roadside, and first notice of loss services.

About CNTA Centessa Pharmaceuticals plc

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.

Share on Social Networks: